clinical studies of patients receiving this infusion less than 15 hours after the onset of symptoms of acute myocardial infarction suggest a reduction in mortality , an improvement in left ventricular mechanical performance , and a reduction in cardiac irritability as beneficial effects .
C0027051
myocardial infarction
C0018787
cardiac